Efficacy of Pirtobrutinib in Covalent BTK-Inhibitor Pre-Treated Relapsed / Refractory CLL/SLL: Additional Patients and Extended Follow-up from the Phase 1/2 BRUIN Study

Mato, A. R., Woyach, J. A., Brown, J. R., Ghia, P., Patel, K., Eyre, T. A., Munir, T., Lech-Marańda, E., Lamanna, N., Tam, C. S., Seymour, J. F., Shah, N. N., Coombs, C. C., Ujjani, C. S., Patel, M. R., Fakhri, B., Cheah, C. Y., Alencar, A. J., Cohen, J. B., … Jurczak, W. (2022). Efficacy of Pirtobrutinib in Covalent BTK-Inhibitor Pre-Treated Relapsed / Refractory CLL/SLL: Additional Patients and Extended Follow-up from the Phase 1/2 BRUIN Study. Blood, 140(Supplement 1), 2316–2320. https://doi.org/10.1182/blood-2022-159497
Authors:
Anthony R. Mato
Jennifer A. Woyach
Jennifer R. Brown
Paolo Ghia
Krish Patel
Toby A. Eyre
Talha Munir
Ewa Lech‐Marańda
Nicole Lamanna
Constantine S. Tam
John F. Seymour
Nirav N. Shah
Catherine C. Coombs
Chaitra S. Ujjani
Manish R. Patel
Bita Fakhri
Chan Y. Cheah
Alvaro J. Alencar
Jonathon B. Cohen
James N. Gerson
Ian W. Flinn
Shuo Ma
Deepa Jagadeesh
Joanna Rhodes
Francisco J. Hernandez‐Ilizaliturri
Pier Luigi Zinzani
Minna Balbas
Binoj C. Nair
Paolo Abada
Chunxiao Wang
Denise Wang
Donald E. Tsai
William G. Wierda
Wojciech Jurczak
Affiliated Authors:
Jennifer A. Woyach
Nicole Lamanna
Columbia Affiliation:
Subjects:
Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1182/blood-2022-159497
DOI:
10.1182/blood-2022-159497
Journal:
Blood
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: